OCUPRESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ocupress, and what generic alternatives are available?
Ocupress is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in OCUPRESS is carteolol hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ocupress
A generic version of OCUPRESS was approved as carteolol hydrochloride by SANDOZ on January 3rd, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUPRESS?
- What are the global sales for OCUPRESS?
- What is Average Wholesale Price for OCUPRESS?
Summary for OCUPRESS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Patent Applications: | 822 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OCUPRESS at DailyMed |
US Patents and Regulatory Information for OCUPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | OCUPRESS | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019972-001 | May 23, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OCUPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | OCUPRESS | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019972-001 | May 23, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | OCUPRESS | carteolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019972-001 | May 23, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OCUPRESS
See the table below for patents covering OCUPRESS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S4948683 | ⤷ Sign Up | |
Argentina | 209575 | UN PROCEDIMIENTO PARA PREPARAR NUEVOS DERIVADOS SUSTITUIDOS DE 5-,6-,7-U8-(3-AMINO-2-OXISUSTITUIDO)-PROPOXI-3,4-DIHIDROCARBOSTIRILO Y DE 5-,6-,7-U8-(3-AMINO-2-HIDROXI)PROPOXI -3,4-DIHIDROCARBOSTIRILO | ⤷ Sign Up |
Spain | 412484 | ⤷ Sign Up | |
Yugoslavia | 254979 | ⤷ Sign Up | |
Sweden | 451069 | ANVENDNING AV ETT KARBOSTYRILDERIVAT FOR FRAMSTELLNING AV ETT LEKEMEDEL FOR BEHANDLING AV GLAUKOM | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |